Ibiglustat
Catalog No.
BA8492
Ibiglustat (Venglustat) is an orally active, blood-brain barrier-crossing inhibitor of glucose ceramide synthetase.
Featured Products
Ibiglustat (Venglustat) is an orally active, blood-brain barrier-crossing inhibitor of glucose ceramide synthetase.Ibiglustat is used in the study of Gaucher's disease type 3, Parkinson's disease associated with GBA mutations, Fabry's disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease.
| Physical Appearance | A solid |
| Storage | -20°C |
| M.Wt | 389.49 |
| Cas No. | 1401090-53-6 |
| Formula | C20H24FN3O2S |
| Synonyms | Venglustat;SAR402671;GZ402671 |
| Solubility | ≥45.1 mg/mL in DMSO; ≥38.9 mg/mL in EtOH; insoluble in H2O |
| Chemical Name | (S)-quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate |
| SDF | Download SDF |
| Canonical SMILES | O=C(NC(C)(C)C1=CSC(C2=CC=C(F)C=C2)=N1)O[C@@H]3CN4CCC3CC4 |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
Chemical structure
